Barclays PLC Tandem Diabetes Care Inc Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Barclays PLC holds 231,065 shares of TNDM stock, worth $8.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

231,065

Previous 231,065 -0.0%

Holding current value

$8.3 Million

Previous $9.8 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$35.21 - $47.3 $6.15 Million - $8.26 Million	-174,647 Reduced 43.05%	231,065 $9.8 Million
Q2 2024 Aug 14, 2024	BUY	$30.43 - $53.43 $10.8 Million - $19 Million	355,915 Added 714.73%	405,712 $16.3 Million
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $3,247 - $5,205	147 Added 0.3%	49,797 $1.76 Million
Q4 2023 Feb 15, 2024	SELL	$14.28 - $31.03 $492,517 - $1.07 Million	-34,490 Reduced 40.99%	49,650 $1.47 Million
Q3 2023 Nov 07, 2023	BUY	$19.33 - $36.22 $348,423 - $652,865	18,025 Added 27.26%	84,140 $1.75 Million
Q2 2023 Aug 03, 2023	SELL	$24.18 - $42.46 $838,006 - $1.47 Million	-34,657 Reduced 34.39%	66,115 $1.62 Million
Q1 2023 May 04, 2023	BUY	$35.86 - $46.5 $484,612 - $628,401	13,514 Added 15.49%	100,772 $4.09 Million
Q4 2022 Feb 13, 2023	SELL	$35.49 - $56.15 $510,417 - $807,549	-14,382 Reduced 14.15%	87,258 $3.92 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $68.97 $436,155 - $687,423	-9,967 Reduced 8.93%	101,640 $4.86 Million
Q2 2022 Aug 12, 2022	BUY	$53.22 - $123.09 $295,690 - $683,888	5,556 Added 5.24%	111,607 $6.61 Million
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $366,192 - $539,423	3,594 Added 3.51%	106,051 $12.3 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $2.82 Million - $3.66 Million	-23,876 Reduced 18.9%	102,457 $15.4 Million
Q3 2021 Nov 09, 2021	BUY	$93.51 - $129.4 $566,296 - $783,646	6,056 Added 5.04%	126,333 $15.1 Million
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $873,488 - $1.14 Million	-11,344 Reduced 8.62%	120,277 $11.7 Million
Q1 2021 May 13, 2021	BUY	$81.28 - $104.34 $2.9 Million - $3.72 Million	35,625 Added 37.11%	131,621 $11.6 Million
Q4 2020 Feb 11, 2021	BUY	$86.4 - $121.75 $882,748 - $1.24 Million	10,217 Added 11.91%	95,996 $9.19 Million
Q3 2020 Nov 12, 2020	SELL	$95.43 - $116.09 $1.5 Million - $1.82 Million	-15,701 Reduced 15.47%	85,779 $9.74 Million
Q2 2020 Aug 12, 2020	BUY	$60.05 - $98.92 $4.83 Million - $7.96 Million	80,443 Added 382.39%	101,480 $10 Million
Q1 2020 May 13, 2020	SELL	$47.37 - $90.04 $3.68 Million - $6.99 Million	-77,584 Reduced 78.67%	21,037 $1.36 Million
Q4 2019 Feb 10, 2020	BUY	$53.13 - $71.19 $3.42 Million - $4.59 Million	64,409 Added 188.26%	98,621 $5.88 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $589,603 - $756,749	-10,324 Reduced 23.18%	34,212 $2.02 Million
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $491,213 - $647,307	9,028 Added 25.43%	44,536 $2.87 Million
Q1 2019 May 15, 2019	SELL	$32.25 - $73.56 $195,241 - $445,332	-6,054 Reduced 14.57%	35,508 $2.26 Million
Q4 2018 Feb 14, 2019	SELL	$28.45 - $40.65 $1.38 Million - $1.98 Million	-48,656 Reduced 53.93%	41,562 $1.58 Million
Q3 2018 Nov 14, 2018	BUY	$21.39 - $51.17 $693,977 - $1.66 Million	32,444 Added 56.16%	90,218 $3.87 Million
Q2 2018 Aug 14, 2018	BUY	$4.9 - $23.64 $52,302 - $252,333	10,674 Added 22.66%	57,774 $1.27 Million
Q1 2018 May 15, 2018	BUY	$2.35 - $4.96 $47,705 - $100,688	20,300 Added 75.75%	47,100 $234,000
Q4 2017 Feb 14, 2018	BUY	$2.24 - $8.2 $60,032 - $219,759	26,800	26,800 $63,000

Others Institutions Holding TNDM

# of Institutions

360

Shares Held

72.2M

Call Options Held

3.36M

Put Options Held

229K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.31B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account